Eye On Quality And Price, Govt Plans Single Platform To Source Medicines

MUMBAI : The government plans to create a common platform to handle procurement of medicines for all Central government agencies, including the Central Government Health Scheme (CGHS), institutions and public sector undertakings. The objective is to reap the benefits of a bulk purchase through a common mechanism, where drugs will be of uniform quality and pricing, across the country.

Overall, Central and state governments’ drug procurement is estimated to be Rs 22,000 crore annually, or about 15% of the total pharma market.

At present, the same medication may be purchased by different government organisations and separate ministries — health and chemicals & fertilisers, at different prices. Significantly, the move could also prevent the practice of over-billing by certain pharma companies, and offer high-value critical products at a reduced price, resulting in huge savings for the government, sources told TOI.

A major part of the government procurement is used for schemes and institutions including Jan aushadhi, CGHS, AIIMS and Employees’ State Insurance Corporation. The mechanism being discussed is only for procurement by the Centre, as states have their independent system in place.

The matter has been discussed by both ministries — health & family welfare and Chemicals & Fertilisers with presentations made by entities including GeM (Government e-Market Place), sourcesadded. Among the possible entities which could be roped in include GeM and Indian Drugs and Pharmaceuticals Ltd. Further, for sourcing products like vitamins, basic antibiotics and paracetamol preference could be given to micro, small and medium enterprises, sources said.

  • Related Posts

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Pune:  After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…

    Spurious cosmetic packaging factory busted in northwest Delhi

    New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Spurious cosmetic packaging factory busted in northwest Delhi

    Spurious cosmetic packaging factory busted in northwest Delhi

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    UP plans US FDA-accredited medical device testing lab

    UP plans US FDA-accredited medical device testing lab

    Patent rejected for MNC’s cancer drug, generics to follow

    Patent rejected for MNC’s cancer drug, generics to follow

    Zydus brings world’s first Nivolumab biosimilar to India

    Zydus brings world’s first Nivolumab biosimilar to India